$23.29
Today
as of Sep 4, 16:51 ET
Last 30 days
Recent Press Releases & News
Why MiniMed Stock Was Soaring This Week
MiniMed Group (MMED) Starts Fiscal 2027 Strong As Product And Regulatory Progress Builds
UBS Raises Price Target on MiniMed to $28 From $25, Keeps Buy Rating
Overview
52-week range
$11
$24
92% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Latest IV / EM
84%
EM ±13.1% · $23 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri Jan 23, 2026 | Jan 2026 | $-0.47 | — | — | — | — | financials |
| Fri Jan 24, 2025 | Jan 2025 | $-0.04 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | $790M | — | — | — | $687M | — | — |
| Cost of revenue | $428M | — | — | — | $292M | — | — |
| Gross profit | $362M | — | — | — | $395M | — | — |
| Operating income | $-100M | — | — | — | $21M | — | — |
| Net income | $-119M | $-5M | $-16M | — | $-10M | $-5M | $-19M |
| EPS (diluted) | $-0.47 | — | — | — | $-0.04 | — | — |
Balance sheet (quarterly)
| Metric | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $10M | — | — | $11M | — | — | — |
| Inventory | $408M | — | — | $311M | — | — | — |
| Total current assets | $1.11B | — | — | $939M | — | — | — |
| Total assets | $4.34B | — | — | $4.20B | — | — | — |
| Long-term debt | — | — | — | — | — | — | — |
| Total liabilities | $881M | — | — | $871M | — | — | — |
| Total equity | $3.46B | $3.56B | $3.54B | $3.33B | $3.48B | $3.46B | $3.48B |